Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Proteocyte AI logo — Focused on Reducing Cancer Incidence Around the World

Proteocyte AI

Focused on Reducing Cancer Incidence Around the World

Founded 2011 Canada Toronto, Canada 8 employees Seed Total: $605.00K Health Care

General Information

Company Name Proteocyte AI
Founded Year 2011
Location Canada Toronto, Canada
Employees 8
Industries Health Care
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Proteocyte AI. To contact Proteocyte AI, visit proteocyte.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Proteocyte AI compare?

A PDF of Proteocyte AI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Proteocyte AI soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Proteocyte AI

Proteocyte AI is a Health Care startup founded in 2011 and based in Canada. The company is focused on Reducing Cancer Incidence Around the World through the development of tests that accurately predict the risk of developing cancer. Their platform utilizes specific protein biomarkers, proprietary algorithms, and advanced imaging to predict the probability of non-cancerous lesions progressing to invasive cancer. Their first product, Straticyte, is the first digitally delivered oral cancer predictor. In November 2014, Proteocyte AI received a Seed Round investment from Wilfrid Laurier University, Golden Triangle Angel Network, and Freycinet Ventures. The company's mission is to save patients’ lives by predicting progression to cancer, ultimately reducing the global incidence of cancer. Proteocyte AI's innovative solutions aim to provide healthcare professionals with valuable insights for earlier diagnosis and treatment, leading to improved outcomes and extended lives for patients worldwide.

Business keywords: Cancer Prevention, Molecular Diagnostics, Predictive Testing, Cancer Risk Assessment, Digital Pathology, Healthcare Innovation, Protein Biomarkers, Diagnostic Imaging, Early Cancer Detection, Medical Technology, Healthcare Analytics

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 3
Wilfrid Laurier University
Wilfrid Laurier University, Golden Triangle Angel Network +1
27 Nov 2014
Seed Round $605.00K 1
Ontario Centres of Excellence
Ontario Centres of Excellence
13 Aug 2014

Proteocyte AI Alternatives & Competitors

Proteocyte AI vs
Cyted Health
Cyted Health United Kingdom

Transforming access to digestive health for everyone, everywhere.

Non Equity Assistance
74 employees
AI, Biotechnology
Compare Proteocyte AI vs Cyted Health
Proteocyte AI vs
Vigilant Biosciences, Inc.
Vigilant Biosciences, Inc. United States

Vigilant Biosciences is a leading innovator and developer of solutions that aid clinicians in the ea...

Venture round
21 employees
Biotechnology, Health Care
Proteocyte AI vs
PreCyte Inc
PreCyte Inc United States

Envisioning a world free from cancer and neurodegenerative disease

3 employees
Biotechnology, Health Care

FAQ About Proteocyte AI

Focused on Reducing Cancer Incidence Around the World
Proteocyte AI was founded in 2011.
Proteocyte AI is headquartered in Toronto, Canada.
Proteocyte AI operates in Health Care. Its work centres on Cancer Prevention, Molecular Diagnostics, Predictive Testing and Cancer Risk Assessment.
Proteocyte AI has approximately 8 employees.
Proteocyte AI has completed 2 funding rounds, raising a total of $605.00K. The latest funding stage is Seed.
Top alternatives and competitors to Proteocyte AI include Cyted Health, Vigilant Biosciences, Inc., PreCyte Inc, bioAffinity Technologies, Viome Life Sciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Proteocyte AI and Cyted Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Proteocyte AI, https://bouncewatch.com/company/proteocyte-ai, updated 29 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes